Clinical Trials in Chicago

Showing 3441-3460 of 9,860 trials

COMPLETEDNA2.2 miles

Rewards Sensitivity After Brain Injury

NCT06510023

A study measuring rewards sensitivity in individuals with acquired brain injury at an acute rehabilitation level.

Acquired Brain Injury

Shirley Ryan AbilityLab31 participantsStarted Mar 2021

Chicago, Illinois, United States

COMPLETEDPhase 22.2 miles

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis

NCT05080660

The purpose of this study is to test safety and efficacy of study drug LY3526318 in for the treatment of knee pain due to with osteoarthritis (OA). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292) which is a protocol to accelerate the development of new treatments for chronic pain.

OsteoarthritisOsteo Arthritis Knee

Eli Lilly and Company160 participantsStarted Oct 2021

Chandler, Arizona, United States • Glendale, Arizona, United States • Tempe, Arizona, United States +27 more locations

Rewards Sensitivity After Brain Injury

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis

Find Trials by Condition in Chicago

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

Recovery Management Checkups for Primary Care Experiment

External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO)

Population Effects of MI on Pediatric Obesity in Primary Care

Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism

A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors

Adjunct Collection of Additional Biorepository Data From Patients Enrolled in Diabetic Foot Consortium (DFC) Trials

C-myc Biomarker Study for Diabetic Foot Ulcers

Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer

Belimumab Assessment of Safety in SLE

A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer

Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC

Study of VIB7734 for the Treatment of Moderate to Severely Active SLE

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa